Рет қаралды 49
Claudio Cerchione - Agile: a global, randomized, double-blind, phase 3 study of Ivosidenib + Azacitidine versus Placebo + Azacitidine in patients with newly diagnosed Acute Myeloid Leukemia with an IDH1 mutation
If you don't want to miss the new interviews and all the insights of the speakers don't forget to follow us on all social channels!
All speachs are available on our website: www.sohoitaly....
and on our youtube channel: • 4th Soho Italy Annual ...